Moreover, previous consideration of NMDA receptor antagonism as potential treatment for binge-eating disorder suggests that the weight-lowering benefits linked to GLP-1–MK-801 could be the result of a combined impact on both energy homeostasis and disordered eating behaviours10,14,41. The gene discussed is GLP1R; the disease is binge eating disorder.